New lung cancer drug shows dramatic results for shrinking tumors
Tuesday, June 22, 2010 - 13:30
in Health & Medicine
Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.